23 reports

  • four centers in the US.
  • FEATURED NEWS & PRESS RELEASES

Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • EXAMPLES OF OUTER, MIDDLE AND INNER EAR DISEASES
  • DRUGS FOR INNER EAR DISEASES: RESEARCH PIPELINE AT UNIVERSITIES

INTRODUCTION A significant proportion of the world’s population is suffering from otologic diseases. Absence of any disease modifying drugs is a big unmet need in the market. The current treatment of inner ear diseases is primarily based on counselling, electric and magnetic nerve stimulations. At the same time, there is a growing...

  • Ear Disease
  • United States
  • AudioCure Pharma GmbH
  • Autifony Therapeutics Limited
  • Cochlear Limited

JUN ##, 2017: SENSORION TAKES A KEY STEP TOWARDS PHASE ## WITH SENS-## THANKS TO THE POSITIVE RESULTS OBTAINED IN THE PHASE ## CLINICAL TRIAL Sensorion, a biotech company specializing in the treatment of inner ear diseases, announces the positive results of the phase

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Molecular Diagnostic
  • Therapy
  • Sensorion S.A.

JUN ##, 2017: SENSORION TAKES A KEY STEP TOWARDS PHASE ## WITH SENS-## THANKS TO THE POSITIVE RESULTS OBTAINED IN THE PHASE ## CLINICAL TRIAL Sensorion, a biotech company specializing in the treatment of inner ear diseases, announces the positive results of the phase

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • World
  • Product Initiative
  • Sensorion S.A.
  • Meniere Disease - Pipeline by Sound Pharmaceuticals Inc, H1 2018
  • Oct 03, 2017: Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Menieres Disease

Meniere Disease - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease - Pipeline Review, H1 2018, provides an overview of the Meniere Disease (Ear Nose Throat Disorders) pipeline landscape. Meniere disease is...

  • Ear Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Otonomy, Inc.
  • Sensorion's Key Drug Pipeline (2017)

Otividex Ménière' s Disease Phase ## Intratympanic Synphora AB Latanoprost Ménière' s Disease Phase ## Intratympanic Sensorion SA SENS-## AUV Phase ## Oral Auris Medical Holding Ag AM-## Ménière' s Disease Phase ## Intranasal Sound Pharmaceutica

  • Ear Disease
  • World
  • Company
  • Forecast
  • Auris Medical Holding AG
  • 1.1 Hearing Loss

It can occur in both or one ear of a person and can be temporary or permanent.

  • Ear Disease
  • World
  • Forecast
  • Market Size
  • Sonova Holding AG
  • Target
  • LATEST CLINICAL TRIALS NEWS ON MENIERE DISEASE

Currently, there are no FDA approved drug treatments for MD, or any other inner ear disease.

  • Ear Disease
  • Hospital
  • World
  • Product Initiative
  • Otonomy, Inc.
  • OR-102 - DRUG PROFILE

It was also under development for the treatment of myocardial infarction, organ transplantation, Meniere disease and Parkinson' s disease (cell transplantation).

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Clinical Trial profile. 35 Trial Title
  • LATEST CLINICAL TRIALS NEWS ON HEARING DISORDERS

Hearing Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hearing Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Hearing Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Hearing Disorders....

  • Clinical Trial
  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • May 22, 2018: Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board
  • Deal Type

This successful transformation has produced a unique screening platform in the highpotential inner-ear diseases sector and its two first drug candidates, SENS-## in phase ## and SENS-## in phase ##.

  • Ear Disease
  • France
  • Company
  • Deals & Alliance
  • Sensorion S.A.
  • Clinical Trial profile. 31 Trial Title
  • Clinical Trial Profile Snapshots

Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017” provides an overview of Acute Sensorineural Hearing Loss clinical trials scenario. This report provides top line data relating...

  • Ear Disease
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES

The Company intends to use the proceeds to accelerate the development of two lead compounds, one a topical treatment for retinal diseases and the second a treatment for neurological diseases.

  • Ear Disease
  • Therapy
  • United States
  • Product Initiative
  • Auris Medical Holding AG
  • Clinical Trial profile. 85 Trial Title
  • Clinical Trial profile. 121 Trial Title

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Clinical Trial
  • Ear Disease
  • Hospital
  • Therapy
  • World
  • Oct 03, 2017: Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Menieres Disease
  • 09/25/2017: Sound Pharmaceuticals initiates STOP Ototoxicity Study in Cystic Fibrosis

The company intends to use the proceeds to develop treatments for inner ear disease.

  • Ear Disease
  • Healthcare
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Sound Pharmaceuticals Inc
  • QPHL-2 - Drug Profile

Patients will receive an administration of OTO-## in one ear prior to each of the first three cisplatin treatment cycles, with the contralateral ear as an untreated control.

  • Ear Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Otonomy, Inc.
  • R&D Progress
  • R&D Progress

THE INVENTION RELATES TO METHODS AND KITS USEFUL FOR PROVIDING NEUROPROTECTION TO NEURONS IN THE INNER EAR AND TO METHODS OF TREATING INNER EAR DISEASES AND DISORDERS, INCLUDING TINNITUS AND MENIERE' S DISEASE.

  • Ear Disease
  • Turkey
  • World
  • Product Initiative
  • Quark

Major driving factors for the market growth are increasing number of patients suffering from hearing problems, ear infection and other diseases have boosted the growth of the market.

  • Ear Disease
  • North America
  • United States
  • World
  • Advanced Bionics Corporation
  • ACUTE SENSORINEURAL HEARING LOSS THERAPEUTICS, GLOBAL, TERMINATED CLINICAL TRIALS, 2015*
  • Trial Results

Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2015" provides an overview of Acute Sensorineural Hearing Loss clinical trials scenario. This report provides top line data relating to...

  • Ear Disease
  • Pharmaceutical
  • World
  • Auris Medical Holding AG
  • Pfizer Inc.

" If successful then we will have a future therapy that we can adapt to combat other diseases caused by bacteria that breed in the nasal pathway such as pneumonia and ear disease.

  • Ear Disease
  • Pharmaceutical
  • Tuberculosis
  • United Kingdom
  • BioInvent
  • Clinical Trial profile. 20 Trial Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Palau Pharma, S.A.

Histamine H4 Receptor (H4R or AXOR35 or G-Protein Coupled Receptor 105 or HRH4 or GPCR105) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histamine H4 Receptor (H4R or AXOR35 or G-Protein Coupled Receptor 105 or HRH4 or GPCR105) - Pipeline Review, H1 2016’, provides in depth analysis on Histamine H4 Receptor...

  • Ear Disease
  • Molecular Diagnostic
  • Turkey
  • World
  • Product Initiative

THE DRUG CANDIDATE BY INHIBITING THE ACTIVITY OF THESES ENZYMES CHECKS THE UNDERLYING CAUSE OF DISEASE.

  • Clinical Trial
  • Drug Discovery And Development
  • Ear Disease
  • World
  • Product Initiative